Relay Therapeutics (RLAY) PT Raised to $23 at Raymond James

April 27, 2026 10:51 AM

Raymond James analyst Sean McCutcheon raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $23.00 (from $19.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found